Search

Home > Industry Focus > Healthcare: Should You Stick With Gilead Sciences?
Podcast: Industry Focus
Episode:

Healthcare: Should You Stick With Gilead Sciences?
Category: Business
Duration: 00:25:14
Publish Date: 2018-06-06 14:30:00
Description:

Gilead Sciences has been one of biopharma's worst performers, and demand for its hepatitis C drugs has yet to bottom. Can its R&D program jump start investor optimism? Stocks: GILD
Total Play: 0

Users also like

0 Episodes
MarketFooler .. 100+     6
700+ Episodes
Rule Breaker .. 200+     6
2K+ Episodes
Motley Fool .. 300+     10+

Some more Podcasts by The Motley Fool

300+ Episodes
Motley Fool ..    
700+ Episodes
Rule Breaker .. 200+     6
400+ Episodes
Motley Fool .. 100+     5
2K+ Episodes
Motley Fool .. 300+     10+
2K+ Episodes
Motley Fool ..